We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




UK Firm to Acquire Orchid's Diagnostic Unit

By HospiMedica staff writers
Posted on 12 Nov 2003
In a move to expand its diagnostic portfolio, Tepnel Life Sciences plc (Manchester, UK) has agreed to acquire the diagnostic unit of Orchid BioSciences, Inc. More...
(Princeton, NJ, USA) for US$4.3million in cash.

Orchid's diagnostic unit provides systems, consumables, and services for human lymphocyte antigen testing (HLA) for organ transplantation matching, tests for cystic fibrosis, and genetic screening. Tepnel will acquire the products and services business of Orchid's diagnostic unit in the USA, the UK, and Belgium. These include Orchid's LifeMatch system and consumable product line for HLA testing and its Elucigene product line for the testing of certain genetic diseases. Tepnel has agreed to assume certain liabilities of Orchid's diagnostic unit and will assume control of the facilities in Stamford (CT, USA) and Brussels (Belgium).

"This will enable the expansion of our diagnostic product and service offerings in Europe and the USA, a key component for the advancement of our corporate strategy,” said Ben Matzilevich, CEO of Tepnel. "We expect that Orchid's well-established HLA typing and Elucigene businesses will provide the expansion and international presence we are aiming for in this key sector.”





Related Links:
Tepnel
Orchid BioSciences

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.